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General Methods
All reagents were obtained from commercial suppliers and were used as supplied without further purification. All batch reactions were performed under an atmosphere of dried argon using standard Schlenk techniques. Anhydrous solvents were obtained from a A Harvard Apparatus syringe pump (70-4501) was used to deliver reagents using syringes to the reactor. The reactor (Vapourtec E-Series, PFA(Perfluoroalkoxy) 1.6mm
(1/16") O.D., 1mm I.D. coil reactor) had a volume of 5 mL. The building blocks were dried using high vacuum prior to use. Prior to delivery of the reagents, the flow system 
General Procedure for the Gold(I)-catalyzed In-flow Glycosylations
A mixture of glycosyl acceptor (0.064 mmol) and glycosyl donor (1.3 eq, 0.084 mmol) was dissolved in CH 2 Cl 2 (847 µL), loaded in a syringe and fitted to the micro reactor (Scheme 1, Image 1). A suspension of (chlorotriphenylphosphoranyl)gold (13 mol%, 4.1 mg, 8.37 µmol) and silvertrifluoromethanesulfonate (13 mol%, 2.2 mg, 8.37 µmol) in CH 2 Cl 2 (847 µL) was sonicated for 1 min, filtered using a syringe tip filter (PTFE membrane, pore size 0.2 µm), loaded in a syringe and also attached to the syringe pump.
The reagents were injected through the reactor with a total flow rate of 250 µL/min while the micro reactor coil was set at the respective temperature using a water bath. After the injection of the reaction mixtures, solvent is injected using the syringe pump to push the reaction mixture through the reactor coil. The combined crude product was filtered over silica plug. Evaporation of the solvent and purification using silica gel chromatography provided the glycosylation product.
All compounds were synthesized according to the representative synthetic procedure in a typical scale between 0.04-0.07 mmol (with respect to the glycosyl acceptor, see above).
The products were obtained after column chromatographic purification in a yield given in the manuscript. The isolated amount is given below.
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Data for Known Compounds
Characterization of all compounds previously reported (5-12, 15-22 and 24-28) was in good agreement with the literature.
Building Block Synthesis:
The reactions were performed according to the literature protocols.
Compound Reference 
In-flow Glycosylations:
The reactions were performed according to the general procedure. 3068, 2927, 2858, 1723, 1642, 1603, 1586, 1493, 1452, 1373, 1316, 1260, 1178, 1091, 1068, 1027, 1002, 937, 912, 854, 803, 738, 706, 686 138.4, 133.4, 133.2, 133.2, 133.1, 129.8, 129.8, 129.7, 129.6, 129.3, 128.8, 128.8, 128.4, 128.3, 128.3, 114.4, 101.3, 72.9, 72.1, 71.9, 70.1, 69.8, 63.2, 33.2, 28.8, 25 3066, 3035, 2879, 1731, 1603, 1586, 1497, 1453, 1361, 1316, 1265, 1178, 1093, 1069, 1028, 854, 802, 738, 709 166.09, 165.82, 165.11, 164.94, 138.45, 138.41, 137.81, 133.40, 133.22, 133.14, 133.08, 129.79, 129.71, 129.51, 129.17, 128.75, 128.71, 128.37, 128.30, 128.01, 127.79, 127.76, 127.59, 127.54, 104.37, 101.31, 84.42, 82.07, 77.77, 75.55, 74.82, 74.64, 74.47, 72.86, 72.13, 71.78, 69.62 2935, 2861, 1779, 1747, 1717, 1642, 1614, 1524, 1470, 1432, 1387, 1367, 1223, 1172, 1105, 1075, 1034, 974, 902, 873, 796, 743, 723 171.0, 170.5, 169.8, 138.5, 134.6, 131.6, 123.9, 114.6, 98.4, 72.1, 71.0, 70.2, 69.3, 62.3, 54.9, 33.3, 28.9, 25.2, 21.1, 20.9, 20.8 0  10  20  30  40  50  60  70  80  90  100  110  120  130  140  150  160  170  180  190  200 f1 (ppm)
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